
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145798310.1021/acsomega.8b02088Article(Diacetoxy)iodobenzene-Mediated Regioselective Imidation
of Imidazoheterocycles with N-Fluorobenzenesulfonimide Singsardar Mukta Mondal Susmita Sarkar Rajib Hajra Alakananda *Department of Chemistry, Visva-Bharati
(A Central University), Santiniketan 731235, India* E-mail: alakananda.hajra@visva-bharati.ac.in (A.H.).03 10 2018 31 10 2018 3 10 12505 12512 18 08 2018 25 09 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Metal-free (diacetoxy)iodobenzene-mediated
regioselective imidation
of imidazoheterocycles using commercially available N-fluorobenzenesulfonimide as an imidating reagent has been developed.
This protocol exhibits broad substrate scope with good to excellent
yields of the imidated imidazopyridines under mild conditions in short
reaction times. The present protocol also represents an efficient
way to access the imidated derivatives of imidazo[2,1-b]thiazole, benzo[d]imidazo-[2,1-b]thiazole, indoles, and indolizines. A radical mechanistic pathway
has been proposed for the present protocol.

document-id-old-9ao8b02088document-id-new-14ao-2018-020884ccc-price
==== Body
Introduction
Imidazopyridine, an
important class of nitrogen-containing fused
heterocyclic motif, is widely present in plant alkaloids and natural
products.1 It is used in pharmaceutical
chemistry as well as in materials science.2 Thus, the development of versatile methods for the synthesis and
functionalization of imidazopyridines is an important field of research
in medicinal and synthetic organic chemistry.3,4 Over
the past decades, considerable efforts have been devoted for the incorporation
of nitrogen functionality in heterocyclic motifs because of their
wide applications in industry and pharmacology.5 Conventionally, aromatic C–N bond formation relies
on the transition-metal-catalyzed C–N cross-coupling reactions,
such as Ullmann–Goldberg, Buchwald–Hartwig, and Chan–Lam
amination.6 These reactions require high
temperature and prefunctionalization of starting materials. Transition-metal-catalyzed
or visible light-induced direct C–H aminations are another
efficient atom-economical coupling processes.7,8 Direct
amination is the direct incorporation of amine or amine derivatives
to a carbon atom through the formation of C–N bond. Beside
these, one more promising strategy of direct C–N couplings
of heteroarenes with preactivated amino precursors has also been reported.9

Over the past decade, the use of N-fluorobenzenesulfonimide
(NFSI) for the amination of aromatic C(sp2)–H bond,10,11 alkenes or unsaturated ketones,12 and
benzylic or allylic C–H bond13 has
been intensely studied by using Pd and Cu catalysts. NFSI can act
as a source of both fluoronium cation for fluorination and nucleophilic
nitrogen or nitrogen radical for amination.14 So far, few groups have explored the transition-metal-catalyzed
amination of arenes with NFSI (Scheme 1a).10 Recently, Pan and
co-workers described a copper-catalyzed imidation of heterocycles
such as thiophene, furan, and pyrrole with NFSI (Scheme 1b).11 Despite these successes, the imidation of other biologically relevant
heterocycles using NFSI under metal-free mild conditions still remains
an interesting and challenging subject for researchers.

Scheme 1 Direct
Amination of Aromatic C–H Bond Using NFSI
Hypervalent iodines(III) are useful oxidants
in various coupling
reactions.15 Moreover, iodine(III)-mediated
intramolecular and intermolecular oxidative aminations have also been
explored to construct diverse heterocyclic compounds.16,17 In this regard, solely di(pivaloyloxy)iodobenzene [PhI(OPiv)2]-mediated oxidative C–H imidation by Wang et al. is
a mentionable work.18 Here, the imidation
of 8-acylaminoquinolines and anilides by NFSI has been carried out
in tetrahydrofuran (THF) at 80 °C for 8 h under metal-free condition.
Very recently, our group reported an efficient method for a regioselective
(diacetoxy)iodobenzene (PIDA)-mediated oxidative amination of imidazopyridines
through C(sp2)–H functionalization leading to 3-amino-substituted
imidazopyridines.4c As a part of our ongoing
investigations on functionalization of imidazoheterocycles,4 herein, we described a metal-free PIDA-mediated
regioselective imidation of imidazoheterocycles with NFSI (Scheme 1c).

Results and Discussion
2-Phenylimidazo[1,2-a]pyridine (1a) was initially selected as a model substrate with NFSI as an imidating
reagent (Table 1).
At first, the reaction was carried out by taking 1a (0.2
mmol) with NFSI (1.0 equiv) at 60 °C in 1,2-DCE for 15 min. However,
no reaction took place, and both 1a and NFSI were recovered
(Table 1, entry 1).
To our delight, in the presence of 1 equiv of PIDA, the reaction afforded N-(2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide (2a) in
68% yield after 15 min (Table 1, entry 2). Further, the yield was not affected when the reaction
was carried out for 1 h. Other solvents, such as THF, CH3CN, toluene, 1,4-dioxane, ethanol, chlorobenzene, and dimethylformamide
(DMF), were also screened under the same conditions (Table 1, entries 3–9). Better
result was obtained in toluene affording 89% of the desired product
(Table 1, entry 5),
whereas very low yield of the desired product was formed with bis(trifluoroacetoxy)iodobenzene
(PIFA) (Table 1, entry
10). Next, we checked the effect of different oxidants such as K2S2O8, TBHP, and H2O2 instead of PIDA (Table 1, entries 11–13). In all cases, only trace amount of
imidated products were detected. The yield of the reaction was decreased
with diminished loading of PIDA to 0.5 equiv but remained unchanged
by increasing the amount to 1.5 equiv (Table 1, entries 14 and 15). No significant improvement
of the yield was found with increasing the reaction temperature, but
the yield was dropped when the reaction was carried out at 40 °C
(Table 1, entries 16
and 17). A trace amount of the desired product 2a were
obtained at room temperature (Table 1, entry 18). Direct imidation product of toulene was
not detected. Summing up, our study led to the following optimized
conditions: 1 equiv of PIDA in toluene at 60 °C for 15 min (Table 1, entry 5).

Table 1 Optimization for the Amination Reactiona
entry	oxidant (equiv)	solvent	yieldb (%)	
1	 	1,2-DCE	0	
2	PIDA (1)	1,2-DCE	68	
3	PIDA (1)	THF	61	
4	PIDA (1)	CH3CN	66	
5	PIDA (1)	toluene	89	
6	PIDA (1)	1,4-dioxane	78	
7	PIDA (1)	EtOH	33	
8	PIDA (1)	chlorobenzene	72	
9	PIDA (1)	DMF	67	
10	PIFA (1)	toluene	18	
11	K2S2O8 (1)	toluene	trace	
12	TBHP (1)	toluene	trace	
13	H2O2 (1)	toluene	trace	
14	PIDA (0.5)	toluene	41	
15	PIDA (1.5)	toluene	90	
16c	PIDA (1)	toluene	88	
17d	PIDA (1)	toluene	59	
18e	PIDA (1)	toluene	trace	
a Reaction conditions: 1a (0.2 mmol), NFSI (1.0 equiv), and oxidant (1.0 equiv) in
the presence
of solvent (1 mL) at 60 °C for 15 min.

b Isolated yields.

c Reaction was carried out at 80 °C.

d Reaction was carried out at 40 °C.

e Reaction was carried out at
rt.

With the optimized reaction
conditions, we explored the substrate
scope of the present protocol, as shown in Scheme 2. A series of C-3 imidated imidazo[1,2-a]-pyridine products were obtained in good to excellent
yields (2a–2t). Imidazo[1,2-a]-pyridines containing electron-donating substituents such as −CH3 and −OCH3 at different positions of the
pyridine ring produced the desired products in excellent yields (2b–2d). Substrates possessing halogen substituents
attached to the six-membered ring successfully underwent the reaction
(2e–2f). 2-Phenyl-6-(trifluoromethyl)imidazo[1,2-a]pyridine successfully reacted with NFSI to furnish the
desired product (2g). Next, we investigated the effect
of substituents at the phenyl ring at the C-2 position of imidazo[1,2-a]pyridine. The phenyl moiety containing both electron-donating
substituents and electron-withdrawing groups gave the corresponding
products in high yields (2h–2p). Hydroxy-containing
imidazo[1,2-a]pyridine was also tolerable for such
transformation (2q). Both naphthyl- and heteroaryl-substituted
imidazopyridines produced the desired products without any difficulties
(2r and 2s). The single-crystal X-ray diffraction
study of N-(phenylsulfonyl)-N-(2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl)benzenesulfonamide (2s) was
performed to confirm the structure of imidated imidazopyridine.19 Isopropyl-substituted (C-2) imidazo[1,2-a]pyridine could also be successfully converted to the corresponding
product in excellent yield (2t). Moreover, no desired
imidated product was obtained when 3-phenylimidazo[1,2-a]pyridine (1u) was reacted with NFSI under the optimized
reaction conditions. This result suggests that the reaction selectively
took place at the C-3 position of imidazo[1,2-a]pyridine.
We also performed the reactions of 1b, 1e, and 1f with dibenzenesulfonimide [HN(SO2Ph)2] instead of NFSI under the same optimized conditions
(Scheme 2). Here, the
corresponding products (2b, 2e, and 2f) were obtained in moderate yields. The gram-scale reaction
was also carried out under the normal laboratory setup by taking 2-phenylimidazo[1,2-a]pyridine (1a) and NFSI under the standard
reaction conditions on a 10 mmol scale. Gratifyingly, N-(2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide (2a) was obtained
without significant decrease in yield which clearly signifies the
practicability of our present protocol.

Scheme 2 Substrate Scope of
Imidazopyridinesa,b,c
Reaction conditions: 1 (0.2 mmol),
NFSI (1.0 equiv), and PIDA (1.0 equiv) in toluene (1 mL) at 60 °C
for 15 min.

10 mmol scale.

Reaction with HN(SO2Ph)2 instead of NFSI.

To extend
the generality of this methodology, we investigated the
present imidation reaction with other heterocycles such as imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazoles (Scheme 3). Both 6-phenylimidazo[2,1-b]thiazole (3a) and 2-phenylbenzo[d]imidazo[2,1-b]thiazole (3b) reacted well to afford the
desired products in satisfactory yields (4a and 4b). 2-Phenylbenzo[d]imidazo[2,1-b]thiazole containing both electron-donating and electron-withdrawing
substituents underwent the reaction with NFSI without any difficulties
(4c–4e). Heteroaryl-substituted benzoimidazothiazole
was also effective for such transformation to afford the desired imidated
product in good yields (4f). However, 4,5-unsubstituted
imidazoles (3g and 3h) did not provide imidated
products under the optimized reaction conditions. The reactions of
imidazothiazole (3a) and benzoimidazothiazole (3b) with HN(SO2Ph)2 produced the desired
imidated products (4a and 4b) in lower yields
(Scheme 3).

Scheme 3 Coupling
of Imidazothiazole and Benzoimidazothiazole with NFSIa,b
Reaction
conditions: 3 (0.2 mmol),
NFSI (1.0 equiv), and PIDA (1.0 equiv) in toluene (1 mL), at 60 °C
for 15 min.

Reaction with
HN(SO2Ph)2 instead of NFSI.

The current methodology is also applicable for N-substituted indole
and indolizine derivatives (Figure 1). Both N-methylindole and 1-methyl-2-phenyl
indole produced the desired products in high yields (5a and 5b). Moreover, indolizine derivatives smoothly
participated in this reaction to give the desired imidated products
in good yields (6a and 6b).

Figure 1 Substrate scope with
other heterocycles. Reaction conditions: N-substituted
indoles or indolizines (0.2 mmol), NFSI (1.0 equiv), and PIDA (1.0
equiv) in toluene (1 mL) at 60 °C for 15 min.

Amino derivative of imidazopyridine (7a) could be
easily synthesized from N-(2 phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2a) using TfOH (Scheme 4).14b

Scheme 4 Synthetic Utility
To acquire the mechanistic
insights into the reaction pathway,
few control experiments were carried out (Scheme 5). It was found that imidazo[1,2-a]pyridine failed to give the corresponding product in the
presence radical scavengers such as 2,2,6,6-tetramethylpiperidine-1-oxyl,
2,6-di-tert-butyl-4-methylphenol, and p-benzoquinone (Scheme 5a). The use of a stoichiometric amount of 1,1-diphenylethylene was
also completely suppressed the imidation reaction. Moreover, N-(2,2-diphenylvinyl)-N-(phenylsulfonyl)benzenesulfonamide
(8a) was obtained in 53% yield along with almost full
recovery of 1a (Scheme 5b). These observations imply that the reaction proceeds
through a radical pathway.

Scheme 5 Control Experiments
On the basis of the control experiments (Scheme 5) as well as previous reports,4c,18,20 a plausible mechanism of PIDA-mediated
C–H imidation of imidazopyridines with NFSI is presented in Scheme 6. Probably, the first
step is the PIDA-mediated oxidation of imidazopyridine (1a) to imidazopyridine radical cation (A) along with the
formation of radical (B) through a single electron-transfer
process. After that the radical (B) is oxidized by NFSI
via one-electron F-atom transfer pathway, affording the bis-sulfonylamidyl
radical (C). On the other hand, dibenzenesulfonimide
[HN(SO2Ph)2] could also produce N-iodoamido species (D) in the presence of PIDA which
subsequently gives bis-sulfonylamidyl radical (C) and
generates imidazopyridine radical cation (A) from 1a. Finally, the resulting imidazopyridine radical cation
(A) regioselectively coupled with the bis-sulfonylamidyl
radical (C) to produce the imidazolenium ion (E) which consequently affords the product (2a) through
the elimination of AcOH.

Scheme 6 Plausible Mechanistic Pathway
Conclusions
In
summary, we have developed an efficient and simple methodology
for PIDA-mediated regioselective imidation of imidazo[1,2-a]pyridines using NFSI as the nitrogen source under metal-free
conditions in short reaction times. The present methodology is also
applicable to other heterocycles such as imidazo[2,1-b]thiazole, benzo[d]imidazo-[2,1-b]thiazole, indole, and indolizine derivatives. Metal-free conditions,
broad substrates scope, fast reactions, and gram-scale synthesis are
the notable advantages of our methodology. To the best of our knowledge,
this is the first report of metal-free imidation of imidazoheterocycles
using NFSI featuring the incorporation of −N(SO2Ph)2 group. We believe that our present protocol will
open a new possibility for the forthcoming more practical and selective
C–N bond formation route of heterocycles under metal-free conditions.

Experimental
Section
General Information
All reagents were purchased from
commercial sources and used without further purification. 1H NMR spectra were determined on a 400 MHz spectrometer as solutions
in CDCl3. Chemical shifts are expressed in parts per million
(δ), and the signals were reported as s (singlet), d (doublet),
t (triplet), m (multiplet), dd (double of doublet), and coupling constants
(J) were given in hertz. 13C{1H} NMR spectra were recorded at 100 MHz in CDCl3 solution.
Chemical shifts as an internal standard are referenced to CDCl3 (δ = 7.26 for 1H and δ = 77.16 for 13C{1H} NMR) as an internal standard. Thin-layer
chromatography (TLC) was done on a silica gel-coated glass slide.
All solvents were dried and distilled before use. Commercially available
solvents were freshly distilled before the reaction. All reactions
involving moisture sensitive reactants were executed using an oven-dried
glassware. X-ray single crystal data were collected using Mo Kα
(λ = 0.71073 Å) radiation with a CCD area detector. Melting
points were determined on a glass disk with an electrical bath and
are uncorrected. All of the imidazoheterocycles were prepared by our
reported method.4b,4d

General Experimental Procedures
for the Synthesis of 2a–2t and 4a–4f
Imidazoheterocycles (0.2
mmol), NFSI (1.0 equiv, 63 mg), and PIDA (1.0 equiv, 65 mg) were taken
in an oven-dried reaction vessel equipped with a magnetic stir bar.
Then, toluene (1 mL) was added and stirred at 60 °C for 15 min.
The progress of the reaction was monitored by TLC. After completion,
the reaction mixture was diluted with 8 mL of water/ethyl acetate
(1:1). Then, the reaction mixture was extracted with ethyl acetate,
and the organic phase was dried over anhydrous Na2SO4. After evaporating the solvent under reduced pressure, the
crude residue was obtained. Finally, it was purified by column chromatography
on silica gel (60–120 mesh) using petroleum ether/ethylacetate
as an eluent to afford the pure imidated products (2a–2t and 4a–4f).

N-(2-Phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2a)
White solid (87 mg, 89%), Rf 0.5 (PET/EtOAc = 3:2), mp 128–130
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.90
(m, 4H),
7.72–7.70 (m, 2H), 7.64 (d, J = 8.8 Hz, 1H),
7.59–7.55 (m, 2H), 7.52–7.50 (m, 1H), 7.41–7.37
(m, 4H), 7.29–7.24 (m, 1H), 7.18–7.14 (m, 1H), 7.12–7.08
(m, 2H), 6.66–6.63 (m, 1H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 145.6, 144.6, 139.2, 134.7, 131.9,
129.2, 129.1, 128.5, 128.2, 127.6, 126.9, 124.0, 118.0, 112.8, 111.1;
Anal. Calcd for C25H19N3O4S2: C, 61.34; H, 3.91; N, 8.58%. Found: C, 61.13; H, 4.02;
N, 8.67%.

N-(8-Methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2b)
White solid (88 mg, 87%), Rf 0.6 (PET/EtOAc = 4:1), mp 116–118
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.90
(m, 4H), 7.75–7.73 (m, 2H), 7.56 (t, J = 7.6
Hz, 2H), 7.38 (t, J = 8.0 Hz, 5H), 7.17–7.08
(m, 3H), 7.05–7.03 (m, 1H), 6.55 (t, J = 6.8
Hz, 1H), 2.65 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 145.3, 144.8, 139.3, 134.6, 132.3, 129.2,
129.1, 128.3, 128.1, 128.0, 127.8, 125.5, 121.7, 112.7, 111.3, 16.6;
Anal. Calcd for C26H21N3O4S2: C, 62.01; H, 4.20; N, 8.34%. Found: C, 62.21; H, 4.09;
N, 8.25%.

N-(7-Methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2c)
White solid (87 mg, 86%), Rf 0.7 (PET/EtOAc = 4:1), mp 78–80
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.90
(m, 4H), 7.69–7.67 (m, 2H), 7.59–7.55 (m, 2H), 7.41–7.37
(m, 6H), 7.15–7.13 (m, 1H), 7.10–7.06 (m, 2H), 6.50–6.48
(m, 1H), 2.40 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 149.0, 145.0, 139.2, 134.7, 132.9, 132.0,
131.8, 129.2, 129.1, 128.4, 128.1, 127.6, 123.2, 116.5, 115.4, 21.4;
Anal. Calcd for C26H21N3O4S2: C, 62.01; H, 4.20; N, 8.34%. Found: C, 62.27; H, 4.32;
N, 8.13%.

N-(7-Methoxy-2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2d)
White solid (91 mg, 88%), Rf 0.5 (PET/EtOAc = 4:1), mp 96–98
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.90
(m, 4H), 7.68–7.66 (m, 2H), 7.58–7.55 (m, 2H), 7.41–7.37
(m, 4H), 7.28 (d, J = 7.6 Hz, 1H), 7.16–7.12
(m, 1H), 7.10–7.06 (m, 2H), 6.92 (d, J = 2.4
Hz, 1H), 6.35 (dd, J = 2.4, 7.2 Hz, 1H), 3.87 (s,
3H); 13C{1H} NMR (CDCl3, 100 MHz):
δ 159.5, 146.3, 145.3, 139.2, 134.7, 131.9, 129.2, 129.1, 128.4,
128.1, 127.4, 124.4, 110.1, 107.7, 95.3, 55.8; Anal. Calcd for C26H21N3O5S2: C,
60.10; H, 4.07; N, 8.09%. Found: C, 59.95; H, 4.15; N, 7.99%.

N-(6-Fluoro-2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2e)
White solid (94 mg, 93%), Rf 0.5 (PET/EtOAc = 3:2), mp 130–132
°C; 1H NMR (CDCl3, 400 MHz): δ 7.93–7.91
(m, 4H), 7.71–7.69 (m, 2H), 7.62–7.58 (m, 3H), 7.43–7.39
(m, 4H), 7.36–7.35 (m, 1H), 7.19–7.16 (m, 2H), 7.12–7.09
(m, 2H); 13C{1H} NMR (CDCl3, 100
MHz): δ 153.4 (d, JC–F =
238.0 Hz), 142.1, 139.1, 134.9, 134.1, 131.7, 129.2 (d, JC–F = 19.0 Hz) 129.0, 128.7, 128.3, 127.5, 119.0,
118.8, 118.6 (d, JC–F = 9.0 Hz),
111.4, 110.9; Anal. Calcd for C25H18FN3O4S2: C, 59.16; H, 3.57; N, 8.28%. Found: C,
59.30; H, 3.68; N, 8.12%.

N-(6-Bromo-2-phenylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2f)
White solid (104 mg, 92%), Rf 0.4 (PET/EtOAc = 3:2), mp 136–138
°C; 1H NMR (CDCl3, 400 MHz): δ 7.94–7.92
(m, 4H), 7.74–7.72 (m, 2H), 7.63–7.58 (m, 2H), 7.51
(d, J = 9.6 Hz, 1H), 7.44–7.40 (m, 5H), 7.32–7.29
(m, 1H), 7.18–7.16 (m, 1H), 7.13–7.09 (m, 2H); 13C{1H} NMR (CDCl3, 100 MHz): δ
142.6, 139.1, 135.1, 130.9, 129.3, 129.0, 128.8, 128.5, 128.4, 127.7,
127.0, 126.1, 124.2, 118.4, 108.1; Anal. Calcd for C25H18BrN3O4S2: C, 52.82; H, 3.19;
N, 7.39%. Found: C, 52.61; H, 3.22; N, 7.48%.

N-(2-Phenyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2g)
White solid (95 mg, 85%), Rf 0.6 (PET/EtOAc = 3:2), mp 124–126
°C; 1H NMR (CDCl3, 400 MHz): δ 7.93
(d, J = 7.6 Hz, 4H), 7.77–7.75 (m, 2H), 7.72
(d, J = 9.6 Hz, 1H), 7.65 (s, 1H), 7.62–7.59
(m, 2H), 7.43–7.37 (m, 5H), 7.22–7.19 (m, 1H), 7.13
(t, J = 7.6 Hz, 2H); 13C{1H}
NMR (CDCl3, 100 MHz): δ 145.8 (d, JC–F = 296.0 Hz), 139.0, 135.1, 131.2, 129.6, 129.4,
129.1, 129.0, 128.8, 128.7, 128.4, 127.7, 126.7, 122.9 (q, JC–F = 6.0, 11.0 Hz), 122.7 (d, JC–F = 2.0 Hz), 118.8; Anal. Calcd for
C26H18F3N3O4S2: C, 56.01; H, 3.25; N, 7.54%. Found: C, 56.18; H, 3.21;
N, 7.40%.

N-(Phenylsulfonyl)-N-(2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)benzenesulfonamide
(2h)
White solid (91 mg, 90%), Rf 0.5 (PET/EtOAc = 7:3), mp 120–122
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.90
(m, 4H), 7.64–7.56 (m, 5H), 7.49–7.47 (m, 1H), 7.41–7.37
(m, 4H), 7.27–7.23 (m, 1H), 6.90 (d, J = 8.0
Hz, 2H), 6.64–6.61 (m, 1H), 2.28 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 145.8, 144.5,
139.3, 138.8, 138.3, 134.5, 129.1, 129.0, 128.9, 127.5, 126.8, 123.9,
117.9, 112.6, 110.8, 21.2; Anal. Calcd for C26H21N3O4S2: C, 62.01; H, 4.20; N, 8.34%.
Found: C, 61.78; H, 4.15; N, 8.46%.

N-(8-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2i)
White solid (97 mg, 94%), Rf 0.5 (PET/EtOAc = 4:1), mp 132–134
°C; 1H NMR (CDCl3, 400 MHz): δ 7.91
(dd, J = 0.6, 8.4 Hz, 4H), 7.26–7.55 (m, 4H),
7.40–7.33 (m, 5H), 7.03 (d, J = 6.8 Hz, 1H),
6.90 (d, J = 8.0 Hz, 2H), 6.53 (t, J = 6.8 Hz, 1H), 2.64 (s, 3H), 2.28 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 145.4, 144.8, 139.3,
138.0, 134.4, 129.3, 129.15, 129.11, 128.9, 127.9, 127.6, 125.5, 121.6,
112.6, 111.1, 21.3, 16.6; Anal. Calcd for C27H23N3O4S2: C, 62.65; H, 4.48; N, 8.12%.
Found: C, 62.49; H, 4.41; N, 8.30%.

N-(2-(4-Methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2j)
White solid (96 mg, 93%), Rf 0.3 (PET/EtOAc = 4:1), mp 119–121
°C; 1H NMR (CDCl3, 400 MHz): δ 7.94–7.92
(m, 4H), 7.67 (d, J = 8.8 Hz, 2H), 7.63–7.58
(m, 3H), 7.47–7.39 (m, 5H), 7.27–7.23 (m, 1H), 6.64–6.60
(m, 3H), 3.78 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 159.9, 145.5, 144.5, 139.3, 134.6, 129.29,
129.22, 129.1, 129.0, 126.8, 124.5, 123.8, 117.8, 113.7, 112.6, 55.3;
Anal. Calcd for C26H21N3O5S2: C, 60.10; H, 4.07; N, 8.09. Found: C, 59.84; H, 4.15;
N, 8.23%.

N-(2-(4-Fluorophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2k)
White solid (95 mg, 94%), Rf 0.6 (PET/EtOAc = 7:3), mp 143–145
°C; 1H NMR (CDCl3, 400 MHz): δ 7.94–7.92
(m, 4H), 7.74–7.70 (m, 2H), 7.61 (t, J = 7.6
Hz, 3H), 7.48 (d, J = 6.8 Hz, 1H), 7.42 (t, J = 8.0 Hz, 4H), 7.30–7.26 (m, 1H), 6.79 (t, J = 8.8 Hz, 2H), 6.67–6.64 (m, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ 162.9 (d, JC–F = 247.0 Hz), 144.7, 144.6, 139.2,
134.8, 129.5 (d, JC–F = 8.0 Hz),
129.2, 129.1, 128.2 (d, JC–F =
2.0 Hz), 127.0, 123.9, 118.0, 115.1 (d, JC–F = 22.0 Hz), 112.8, 111.0; HRMS (ESI–TOF) m/z: [M + H+] calcd for C25H18FN3O4S2, 508.0795;
found, 508.0798.

N-(2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2l)
White solid (96 mg, 92%), Rf 0.6 (PET/EtOAc = 7:3), mp 153–155
°C; 1H NMR (CDCl3, 400 MHz): δ 7.93–7.90
(m, 4H), 7.66–7.60 (m, 5H), 7.48–7.46 (m, 1H), 7.44–7.40
(m, 4H), 7.30–7.27 (m, 1H), 7.07–7.04 (m, 2H), 6.67–6.64
(m, 1H); 13C{1H} NMR (CDCl3, 100
MHz): δ 144.6, 144.5, 139.1, 134.8, 134.6, 130.4, 129.3, 129.1,
128.9, 128.4, 127.2, 126.5, 124.0, 118.1, 113.0; Anal. Calcd for C25H18ClN3O4S2:
C, 57.30; H, 3.46; N, 8.02. Found: C, 57.43; H, 3.38; N, 8.11%.

N-(2-(3-Bromophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2m)
White solid (108 mg, 95%), Rf 0.5 (PET/EtOAc = 7:3), mp 145–147
°C; 1H NMR (CDCl3, 400 MHz): δ 7.84–7.82
(m, 4H), 7.75–7.74 (m, 1H), 7.61–7.49 (m, 5H), 7.34
(t, J = 8.0 Hz, 4H), 7.24–7.18 (m, 2H), 6.89
(t, J = 8.0 Hz, 1H), 6.64–6.61 (m, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ
144.6, 144.0, 138.8, 134.8, 134.0, 132.2, 131.5, 130.4, 129.6, 129.2,
129.0, 127.2, 126.1, 124.1, 122.4, 118.1, 113.1; Anal. Calcd for C25H18BrN3O4S2:
C, 52.82; H, 3.19; N, 7.39%. Found: C, 52.59; H, 3.07; N, 7.28%.

N-(Phenylsulfonyl)-N-(2-(4-(trifluoromethyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzenesulfonamide (2n)
White solid (89 mg, 80%), Rf 0.6 (PET/EtOAc = 3:2), mp 131–133 °C; 1H NMR (CDCl3, 400 MHz): δ 7.92 (dd, J = 0.8, 8.0 Hz, 4H), 7.84 (d, J = 8.0 Hz, 2H), 7.67
(d, J = 9.2 Hz, 1H), 7.61–7.57 (m, 2H), 7.50
(d, J = 6.8 Hz, 1H), 7.42–7.34 (m, 7H), 6.71–6.68
(m, 1H); 13C{1H} NMR (CDCl3, 100
MHz): δ 145.8 (d, JC–F =
218.0 Hz), 139.1, 135.0, 130.3, 130.0, 129.2 (d, JC–F = 18.0 Hz), 128.7, 128.5, 127.8, 127.4, 126.6,
125.4, 125.1 (q, JC–F = 5.0, 9.0
Hz), 124.0, 118.3, 113.2; Anal. Calcd for C26H18F3N3O4S2: C, 56.01; H,
3.25; N, 7.54%. Found: C, 56.20; H, 3.33; N, 7.45%.

N-(2-(3-Nitrophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2o)
White solid (89 mg, 83%), Rf 0.6 (PET/EtOAc = 3:2), mp 155–157
°C; 1H NMR (CDCl3, 400 MHz): δ 8.47–7.46
(m, 1H), 8.06–8.04 (m, 1H), 7.94–7.91 (m, 1H), 7.86
(d, J = 7.6 Hz, 4H), 7.62–7.59 (m, 1H), 7.52–7.48
(m, 3H), 7.33 (t, J = 8.0 Hz, 4H), 7.29–7.19
(m, 2H), 6.68–6.65 (m, 1H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 148.2, 144.7, 142.8, 138.9, 134.9,
133.2, 132.2, 132.1, 129.3, 129.1, 128.6, 127.6, 124.1, 123.1, 122.4,
118.2, 113.4; Anal. Calcd for C25H18N4O6S2: C, 56.17; H, 3.39; N, 10.48%. Found:
C, 56.03; H, 3.36; N, 10.53%.

N-(2-(4-Cyanophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2p)
White solid (77 mg, 75%), Rf 0.7 (PET/EtOAc = 3:2); mp 156–158
°C; 1H NMR (CDCl3, 400 MHz): δ 7.96–7.94
(m, 4H), 7.88–7.86 (m, 2H), 7.68–7.64 (m, 3H), 7.51–7.44
(m, 5H), 7.41–7.39 (m, 2H), 7.36–7.31 (m, 1H), 6.73–6.69
(m, 1H); 13C{1H} NMR (CDCl3, 100
MHz): δ 144.8, 143.2, 139.0, 136.5, 135.0, 132.7, 131.9, 129.4,
129.1, 127.9, 127.5, 124.0, 118.8, 118.3, 113.3, 111.7; Anal. Calcd
for C26H18N4O4S2: C, 60.69; H, 3.53; N, 10.89%. Found: C, 60.54; H, 3.44; N, 10.76%.

N-(2-(2-Hydroxyphenyl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2q)
White solid (74 mg, 73%), Rf 0.4 (PET/EtOAc = 7:3), mp 139–140
°C; 1H NMR (CDCl3, 400 MHz): δ 12.9
(br s, 1H), 7.96 (dd, J = 0.8, 8.4 Hz, 4H), 7.64–7.56
(m, 4H), 7.45 (t, J = 8.0 Hz, 4H), 7.35–7.31
(m, 1H), 7.23–7.21 (m, 1H), 7.07–7.02 (m, 1H), 6.90–6.88
(m, 1H), 6.73–6.69 (m, 1H), 6.28–6.24 (m, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ
158.1, 144.2, 142.2, 139.1, 135.2, 135.0, 130.6, 129.3, 129.2, 127.7,
126.7, 123.8, 118.4, 117.5, 117.0, 114.2, 113.4; Anal. Calcd for C25H19N3O5S2: C,
59.39; H, 3.79; N, 8.31%. Found: C, 59.16; H, 3.84; N, 8.17%.

N-(2-(Naphthalen-2-yl)imidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2r)
White solid (85 mg, 79%), Rf 0.5 (PET/EtOAc = 7:3), mp 150–152
°C; 1H NMR (CDCl3, 400 MHz): δ 8.14
(s, 1H), 7.84–7.78 (m, 5H), 7.65–7.53 (m, 3H), 7.50
(d, J = 8.0 Hz, 2H), 7.38–7.28 (m, 4H), 7.22–7.15
(m, 5H), 6.62–6.58 (m, 1H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 145.5, 144.7, 139.1, 134.5, 133.3,
133.0, 132.2, 129.1, 129.0, 128.8, 128.6, 127.7, 127.3, 127.09, 127.06,
126.5, 125.8, 125.2, 124.0, 118.0, 112.9; Anal. Calcd for C29H21N3O4S2: C, 64.55;
H, 3.92; N, 7.79%. Found: C, 64.41; H, 3.85; N, 7.92%.

N-(Phenylsulfonyl)-N-(2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl)benzenesulfonamide (2s)
White solid (85 mg, 86%), Rf 0.4 (PET/EtOAc = 7:3); mp 137–139 °C; 1H NMR (CDCl3, 400 MHz): δ 7.90–7.88 (m, 4H),
7.53 (t, J = 8.0 Hz, 3H), 7.38–7.34 (m, 5H),
7.20–7.16 (m, 1H), 7.09 (d, J = 5.2 Hz, 1H),
6.99–6.98 (m, 1H), 6.62–6.55 (m, 2H); 13C{1H} NMR (CDCl3, 100 MHz): δ 144.6, 141.2,
139.5, 134.8, 134.6, 129.2, 129.0, 128.9, 127.8, 127.1, 126.7, 126.1,
123.7, 117.8, 112.9; HRMS (ESI–TOF) m/z: [M + H+] calcd for C23H17N3O4S3, 496.0454; found, 496.0455.

N-(2-Isobutylimidazo[1,2-a]pyridin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(2t)
White solid (80 mg, 85%), Rf 0.5 (PET/EtOAc = 8:2), mp 83–85
°C; 1H NMR (CDCl3, 400 MHz): δ 7.97
(d, J = 7.2 Hz, 4H), 7.73–7.69 (m, 2H), 7.55
(t, J = 7.6 Hz, 6H), 7.24–7.20 (m, 1H), 6.67–6.63
(m, 1H), 2.23–2.20 (m, 1H), 1.89 (d, J = 7.2
Hz, 2H), 0.84 (d, J = 6.4 Hz, 6H); 13C{1H} NMR (CDCl3, 100 MHz): δ 149.3, 144.7,
139.1, 134.7, 129.4, 129.1, 128.9, 126.3, 123.4, 117.5, 112.5, 35.7,
27.2, 22.8; Anal. Calcd for C23H23N3O4S2: C, 58.83; H, 4.94; N, 8.95%. Found: C,
58.97; H, 5.02; N, 8.83%.

N-(6-Phenylimidazo[2,1-b]thiazol-5-yl)-N-(phenylsulfonyl)benzenesulfonamide
(4a)
White solid (74 mg, 75%), Rf 0.4 (PET/EtOAc = 4:1), mp 118–120
°C; 1H NMR (CDCl3, 400 MHz): δ 7.92–7.89
(m, 4H),
7.59–7.54 (m, 4H), 7.42–7.38 (m, 4H), 7.13–7.06
(m, 3H), 6.70–6.66 (m, 2H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 150.1, 147.2, 138.9, 134.7, 131.9,
129.9, 129.2, 128.9, 128.2, 128.1, 126.8, 118.1, 113.1; Anal. Calcd
for C23H17N3O4S3: C, 55.74; H, 3.46; N, 8.48%. Found: C, 55.62; H, 3.50; N, 8.31%.

N-(2-Phenylbenzo[d]imidazo[2,1-b]thiazol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(4b)
White solid (85 mg, 78%), Rf 0.5 (PET/EtOAc = 4:1), mp 144–146
°C; 1H NMR (CDCl3, 400 MHz): δ 7.97–7.95
(m, 4H), 7.67–7.65 (m, 2H), 7.62 (d, J = 8.0
Hz, 1H), 7.56–7.52 (m, 2H), 7.35 (t, J = 8.4
Hz, 4H), 7.22–7.19 (m, 1H), 7.11–7.09 (m, 1H), 7.07–7.03
(m, 2H), 6.91–6.89 (m, 2H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 147.4, 138.9, 134.7, 131.8, 130.2,
129.9, 129.6, 129.0, 128.9, 128.5, 128.2, 128.1, 127.0, 125.7, 124.9,
123.8, 114.5; Anal. Calcd for C27H19N3O4S3: C, 59.43; H, 3.51; N, 7.70%. Found: C,
59.69; H, 3.64; N, 7.61%.

N-(7-Methyl-2-phenylbenzo[d]imidazo[2,1-b]thiazol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(4c)
White solid (90 mg, 80%), Rf 0.6 (PET/EtOAc = 4:1); mp 135–137
°C; 1H NMR (CDCl3, 400 MHz): δ 7.95
(dd, J = 0.8, 8.4 Hz, 4H), 7.65–7.62 (m, 2H),
7.54 (t, J = 7.6 Hz, 2H), 7.41 (s, 1H), 7.35 (t, J = 8.0 Hz, 4H), 7.10–7.02 (m, 3H), 6.78 (d, J = 8.4 Hz, 1H), 6.70 (dd, J = 0.8, 8.8
Hz, 1H), 2.37 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 147.1, 138.9, 135.1, 134.7, 131.9, 130.0,
129.9, 129.6, 129.0, 128.5, 128.16, 128.11, 126.9, 126.7, 123.8, 114.1,
113.9, 21.3; Anal. Calcd for C28H21N3O4S3: C, 60.09; H, 3.78; N, 7.51%. Found: C,
59.80; H, 3.71; N, 7.65%.

N-(7-Methoxy-2-phenylbenzo[d]imidazo[2,1-b]thiazol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(4d)
White solid (83 mg, 72%), Rf 0.4 (PET/EtOAc = 4:1), mp 170–172
°C; 1H NMR (CDCl3, 400 MHz): δ 7.95
(d, J = 7.2 Hz, 4H), 7.64–7.62 (m, 2H), 7.54
(t, J = 7.6 Hz, 2H), 7.35 (t, J =
8.0 Hz, 4H), 7.12–7.01 (m, 4H), 6.80 (d, J = 8.8 Hz, 1H), 6.46 (dd, J = 2.4, 9.2 Hz, 1H),
3.80 (s, 3H); 13C{1H} NMR (CDCl3,
100 MHz): δ 157.0, 138.9, 134.7, 132.0, 131.3, 129.5, 129.1,
128.8, 128.3, 128.1, 128.0, 126.8, 126.5, 126.1, 115.1, 113.1, 107.9,
55.9; Anal. Calcd for C28H21N3O5S3: C, 58.42; H, 3.68; N, 7.30%. Found: C, 58.64;
H, 3.74; N, 7.22%.

N-(7-Chloro-2-phenylbenzo[d]imidazo[2,1-b]thiazol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(4e)
White solid (81 mg, 70%), Rf 0.3 (PET/EtOAc = 4:1), mp 125–127
°C; 1H NMR (CDCl3, 400 MHz): δ 7.96–7.94
(m, 4H), 7.65–7.60 (m, 2H), 7.58–7.54 (m, 2H), 7.37
(t, J = 8.0 Hz, 4H), 7.31–7.28 (m, 1H), 7.12–7.10
(m, 1H), 7.08–7.03 (m, 2H), 6.89–6.86 (m, 1H), 6.82
(d, J = 8.8 Hz, 1H); 13C{1H}
NMR (CDCl3, 100 MHz): δ 138.8, 134.8, 131.6, 130.5,
129.6, 129.5, 129.49, 129.44, 129.1, 128.3, 128.2, 128.0, 127.5, 126.9,
126.0, 123.5, 115.1; Anal. Calcd for C27H18ClN3O4S3: C, 55.90; H, 3.13; N, 7.24%. Found:
C, 56.14; H, 3.05; N, 7.08%.

N-(Phenylsulfonyl)-N-(2-(thiophen-2-yl)benzo[d]imidazo[2,1-b]thiazol-3-yl)benzenesulfonamide
(4f)
White solid (75 mg, 68%), Rf 0.7 (PET/EtOAc = 7:3); mp 132–134
°C; 1H NMR (CDCl3, 400 MHz): δ 8.01
(dd, J = 1.2, 8.8 Hz, 4H), 7.62–7.56 (m, 3H),
7.42–7.38 (m, 4H), 7.21 (t, J = 7.2 Hz, 1H),
7.11 (dd, J = 0.8, 4.8 Hz, 1H), 6.97–6.96
(m, 1H), 6.93–6.89 (m, 1H), 6.83 (d, J = 8.0
Hz, 1H), 6.64–6.62 (m, 1H); 13C{1H} NMR
(CDCl3, 100 MHz): δ 139.2, 134.7, 131.8, 129.9, 129.5,
129.1, 127.8, 127.5, 126.0, 125.8, 125.1, 125.0, 124.4, 123.8, 123.7,
114.3, 110.9; Anal. Calcd for C25H17N3O4S4: C, 54.43; H, 3.11; N, 7.62%. Found: C,
54.68; H, 3.02; N, 7.47%.

N-(1-Methyl-1H-indol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(5a)
White solid (65 mg, 76%), Rf 0.4 (PET/EtOAc = 4:1); mp 78–80
°C; 1H NMR (CDCl3, 400 MHz): δ 7.94–7.91
(m, 4H),
7.72–7.68 (m, 2H), 7.59–7.53 (m, 5H), 7.31–7.27
(m, 2H), 7.17–7.13 (m, 1H), 6.23 (s, 1H), 3.33 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ
138.8, 136.4, 134.4, 129.2, 128.9, 127.2, 125.7, 123.7, 121.7, 120.4,
110.2, 104.7, 29.2; Anal. Calcd for C21H18N2O4S2: C, 59.14; H, 4.25; N, 6.57. Found:
C, 59.05; H, 4.19; N, 6.64%.

N-(1-Methyl-2-phenyl-1H-indol-3-yl)-N-(phenylsulfonyl)benzenesulfonamide
(5b)
White solid (79 mg, 79%), Rf 0.5 (PET/EtOAc = 4:1), mp 155–157
°C; 1H NMR (CDCl3, 400 MHz): δ 7.76–7.74
(m, 3H),
7.51 (t, J = 7.6 Hz, 3H), 7.37–7.25 (m, 10H),
7.22–7.16 (m, 1H), 6.93 (t, J = 7.6 Hz, 1H),
6.76 (d, J = 8.0 Hz, 1H), 3.54 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 142.2,
139.9, 135.9, 133.6, 130.5, 129.3, 129.1, 129.0, 128.9, 128.6, 128.4,
125.7, 122.7, 120.9, 119.3, 109.9, 31.4; HRMS (ESI–TOF) m/z: [M + Na+] calcd for C27H22N2O4S2, 525.0913;
found, 525.0917.

N-(1-Cyanoindolizin-3-yl)-N-(phenylsulfonyl)benzenesulfonamide (6a)
White
solid (73 mg, 83%), Rf 0.6 (PET/EtOAc = 4:1), mp 120–122 °C; 1H
NMR (CDCl3, 400 MHz): δ 7.87–7.85 (m, 4H),
7.76–7.70 (m, 3H), 7.68–7.65 (m, 1H), 7.58–7.54
(m, 4H), 7.21–7.17 (m,1H), 6.75–6.72 (m, 1H), 6.63 (s,
1H); 13C{1H} NMR (CDCl3, 100 MHz):
δ 138.3, 137.7, 134.9, 129.5, 128.7, 124.8, 123.5, 119.5, 118.0,
115.6, 114.0, 113.9, 82.2; Anal. Calcd for C21H15N3O4S2: C, 57.65; H, 3.46; N, 9.61.
Found: C, 57.89; H, 3.41; N, 9.51%.

Methyl-3-(N-(phenylsulfonyl)phenylsulfonamido)indolizine-1-carboxylate
(6b)
White solid (73 mg, 78%), Rf 0.5 (PET/EtOAc = 4:1), mp 106–108
°C; 1H NMR (CDCl3, 400 MHz): δ 8.21
(dd, J = 0.8, 8.8 Hz, 1H), 7.86 (dd, J = 0.8, 8.0 Hz, 4H), 7.72–7.67 (m, 3H), 7.53 (t, J = 8.0 Hz, 4H), 7.16–7.12 (m, 1H), 6.91 (s, 1H), 6.68–6.64
(m, 1H), 3.87 (s, 3H); 13C{1H} NMR (CDCl3, 100 MHz): δ 164.7, 138.6, 135.8, 134.6, 129.3, 128.8,
124.6, 123.0, 119.8, 118.9, 113.4, 103.7, 51.2; Anal. Calcd for C22H18N2O6S2: C,
56.16; H, 3.86; N, 5.95%. Found: C, 56.39; H, 3.81; N, 6.04%.

2-Phenylimidazo[1,2-a]pyridin-3-amine (7a)4f
Gummy mass (35 mg,
84%), Rf 0.4 (PET/EtOAc
= 3:2); 1H NMR (CDCl3, 400 MHz): δ 7.98–7.95
(m, 3H), 7.53 (d, J = 9.2 Hz, 1H), 7.47–7.43
(m, 2H), 7.33–7.29 (m, 1H), 7.11–7.07 (m, 1H), 6.79
(t, J = 6.8 Hz, 1H), 3.40 (br s, 2H); 13C{1H} NMR (CDCl3, 100 MHz): δ 143.9,
141.1, 134.6, 130.4, 129.1, 128.8, 127.2, 123.3, 121.9, 117.5, 111.8.

N-(2,2-Diphenylvinyl)-N-(phenylsulfonyl)benzenesulfonamide
(8a)12a
White solid
(50 mg, 53%), Rf 0.3
(PET/EtOAc = 9:1); mp 122–124 °C; 1H NMR (CDCl3, 400 MHz): δ 8.00–7.98 (m, 3H), 7.69–7.67
(m, 3H), 7.59–7.55 (m, 5H), 7.38 (d, J = 8.0
Hz, 3H), 7.30 (s, 1H), 7.24–7.20 (m, 5H), 6.11 (s, 1H); 13C{1H} NMR (CDCl3, 100 MHz): δ
139.9, 138.7, 135.9, 133.9, 130.0, 129.5, 128.9, 128.7, 128.5, 116.4.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b02088.Crystallographic
data for compound 2s (CIF)

Scanned copies of 1H and 13C{1H} NMR spectra of the synthesized compounds
(PDF)



Supplementary Material
ao8b02088_si_001.cif

 ao8b02088_si_002.pdf

 The authors
declare no competing financial interest.

Acknowledgments
A.H. acknowledges
the financial support from SERB-DST
(grant no. EMR/2016/001643). M.S. thanks to UGC-New Delhi (UGC-NFHE-SRF),
S.M. thanks CSIR-New Delhi (CSIR-SRF), and R.S. thanks SERB (N-PDF)
for their fellowships.
==== Refs
References
Enguehard-Gueiffier C. ; Gueiffier A. 
Recent Progress in the Pharmacology of Imidazo[1,2-a]pyridines . Mini-Rev. Med. Chem. 
2007 , 7 , 888 –899 . 10.2174/138955707781662645 .17897079 
Stasyuk A. J. ; Banasiewicz M. ; Cyrański M. K. ; Gryko D. T. 
Imidazo[1,2-a]pyridines
Susceptible to Excited State Intramolecular Proton Transfer: One-Pot
Synthesis via an Ortoleva-King Reaction . J.
Org. Chem. 
2012 , 77 , 5552 –5558 . 10.1021/jo300643w .22662878 
a Bagdi A. K. ; Santra S. ; Monir K. ; Hajra A. 
Synthesis
of Imidazo[1,2-a]pyridines: a Decade Update . Chem. Commun. 
2015 , 51 , 1555 –1575 . 10.1039/c4cc08495k . b Pericherla K. ; Kaswan P. ; Pandey K. ; Kumar A. 
Recent Developments
in the Synthesis of Imidazo[1,2-a]pyridines . Synthesis 
2015 , 47 , 887 –912 . 10.1055/s-0034-1380182 . c Koubachi J. ; El Kazzouli S. ; Bousmina M. ; Guillaumet G. 
Functionalization
of Imidazo[1,2-a]pyridines by Means of Metal-Catalyzed Cross-Coupling
Reactions . Eur. J. Org. Chem. 
2014 , 5119 –5138 . 10.1002/ejoc.201400065 . d Lei S. ; Mai Y. ; Yan C. ; Mao J. ; Cao H. 
A Carbonylation Approach
Toward Activation of Csp2-H and Csp3-H Bonds:
Cu-Catalyzed Regioselective Cross Coupling of Imidazo[1,2-a]pyridines
with Methyl Hetarenes . Org. Lett. 
2016 , 18 , 3582 –3585 . 10.1021/acs.orglett.6b01588 .27388919  e Yang D. ; Yan K. ; Wei W. ; Li G. ; Lu S. ; Zhao C. ; Tian L. ; Wang H. 
Catalyst-Free Regioselective
C-3 Thiocyanation of Imidazopyridines . J. Org.
Chem. 
2015 , 80 , 11073 –11079 . 10.1021/acs.joc.5b01637 .26430797  f Chang Q. ; Liu Z. ; Liu P. ; Yu L. ; Sun P. 
Visible-Light-Induced Regioselective Cyanomethylation of Imidazopyridines
and Its Application in Drug Synthesis . J. Org.
Chem. 
2017 , 82 , 5391 –5397 . 10.1021/acs.joc.7b00750 .28470069  g Cao H. ; Liu X. ; Zhao L. ; Cen J. ; Lin J. ; Zhu Q. ; Fu M. 
One-Pot Regiospecific Synthesis of
Imidazo[1,2-a]pyridines: A Novel, Metal-Free, Three-Component Reaction
for the Formation of C-N, C-O, and C-S Bonds . Org. Lett. 
2014 , 16 , 146 –149 . 10.1021/ol4031414 .24320098  h Donthiri R. R. ; Pappula V. ; Reddy N. N. K. ; Bairagi D. ; Adimurthy S. 
Copper-Catalyzed C-H Functionalization of Pyridines
and Isoquinolines with Vinyl Azides: Synthesis of Imidazo Heterocycles . J. Org. Chem. 
2014 , 79 , 11277 –11284 . 10.1021/jo5021618 .25350716  i Chernyak N. ; Gevorgyan V. 
General and
Efficient Copper-Catalyzed Three-Component Coupling Reaction towards
Imidazoheterocycles: One-Pot Synthesis of Alpidem and Zolpidem . Angew. Chem., Int. Ed. 
2010 , 49 , 2743 –2746 . 10.1002/anie.200907291 .
a Bagdi A. K. ; Hajra A. 
Design, Synthesis, and Functionalization
of Imidazoheterocycles . Chem. Rec. 
2016 , 16 , 1868 –1885 . 10.1002/tcr.201600057 .27272975  b Bagdi A. K. ; Rahman M. ; Santra S. ; Majee A. ; Hajra A. 
Copper-Catalyzed
Synthesis of Imidazo[1,2-a]pyridines through Tandem Imine Formation-Oxidative
Cyclization under Ambient Air: One-Step Synthesis of Zolimidine on
a Gram-Scale . Adv. Synth. Catal. 
2013 , 355 , 1741 –1747 . 10.1002/adsc.201300298 . c Mondal S. ; Samanta S. ; Jana S. ; Hajra A. 
(Diacetoxy)iodobenzene-Mediated
Oxidative C-H Amination of Imidazopyridines at Ambient Temperature . J. Org. Chem. 
2017 , 82 , 4504 –4510 . 10.1021/acs.joc.7b00564 .28383268  d Mishra S. ; Monir K. ; Mitra S. ; Hajra A. 
FeCl3/ZnI2-Catalyzed
Synthesis of Benzo[d]imidazo[2,1-b]thiazole through Aerobic Oxidative
Cyclization between 2-Aminobenzothiazole and Ketone . Org. Lett. 
2014 , 16 , 6084 –6087 . 10.1021/ol5028893 .25393913  e Monir K. ; Bagdi A. K. ; Ghosh M. ; Hajra A. 
Regioselective
Oxidative Trifluoromethylation of Imidazoheterocycles via C(sp2)-H Bond Functionalization . J. Org.
Chem. 
2015 , 80 , 1332 –1337 . 10.1021/jo502928e .25615451  f Monir K. ; Ghosh M. ; Jana S. ; Mondal P. ; Majee A. ; Hajra A. 
Regioselective Synthesis of Nitrosoimidazoheterocycles
using tert-Butyl Nitrite . Org. Biomol. Chem. 
2015 , 13 , 8717 –8722 . 10.1039/c5ob01345c .26178232 
a Amino Group Chemistry, from Synthesis to the Life Sciences ; Ricci A.  , Ed.; Wiley-VCH : Weinheim , 2008 .b Hili R. ; Yudin A. K. 
Making Carbon-Nitrogen
Bonds in Biological and Chemical Synthesis . Nat. Chem. Biol. 
2006 , 2 , 284 –287 . 10.1038/nchembio0606-284 .16710330  c Hartwig J. F. 
Evolution of a Fourth Generation Catalyst for the Amination
and Thioetherification of Aryl Halides . Acc.
Chem. Res. 
2008 , 41 , 1534 –1544 . 10.1021/ar800098p .18681463 
a Brasche G. ; Buchwald S. L. 
CH Functionalization/CN
Bond Formation:
Copper-Catalyzed Synthesis of Benzimidazoles from Amidines . Angew. Chem., Int. Ed. 
2008 , 47 , 1932 –1934 . 10.1002/anie.200705420 . b Monnier F. ; Taillefer M. 
Catalytic
CC, CN, and CO Ullmann-Type Coupling Reactions . Angew. Chem., Int. Ed. 
2009 , 48 , 6954 –6971 . 10.1002/anie.200804497 . c Park Y. ; Kim Y. ; Chang S. 
Transition
Metal-Catalyzed C-H Amination: Scope, Mechanism, and Applications . Chem. Rev. 
2017 , 117 , 9247 –9301 . 10.1021/acs.chemrev.6b00644 .28051855 
For selected reviews on
direct C–H
amination of arenes, see:

a Louillat M.-L. ; Patureau F. W. 
Oxidative C-H Amination
Reactions . Chem. Soc. Rev. 
2014 , 43 , 901 –910 . 10.1039/c3cs60318k .24217419  b Sharma U. ; Kancherla R. ; Naveen T. ; Agasti S. ; Maiti D. 
Palladium-Catalyzed
Annulation of Diarylamines with Olefins through C-H Activation: Direct
Access to N-Arylindoles . Angew. Chem., Int.
Ed. 
2014 , 53 , 11895 –11899 . 10.1002/anie.201406284 . c Sadhu P. ; Punniyamurthy T. 
Copper(II)-Mediated Regioselective
N-Arylation of Pyrroles, Indoles, Pyrazoles and Carbazole via Dehydrogenative
Coupling . Chem. Commun. 
2016 , 52 , 2803 –2806 . 10.1039/c5cc08206d . d Song C. ; Yi H. ; Dou B. ; Li Y. ; Singh A. K. ; Lei A. 
Visible-Light-Mediated
C2-Amination of Thiophenes by Using DDQ as Organophotocatalyst . Chem. Commun. 
2017 , 53 , 3689 –3692 . 10.1039/c7cc01339f .
a Tran B. L. ; Li B. ; Driess M. ; Hartwig J. F. 
Copper-Catalyzed
Intermolecular Amidation and Imidation of Unactivated Alkanes . J. Am. Chem. Soc. 
2014 , 136 , 2555 –2563 . 10.1021/ja411912p .24405209  b Shang M. ; Sun S.-Z. ; Dai H.-X. ; Yu J.-Q. 
Cu(II)-Mediated C-H Amidation and Amination of Arenes: Exceptional
Compatibility with Heterocycles . J. Am. Chem.
Soc. 
2014 , 136 , 3354 –3357 . 10.1021/ja412880r .24527701  c Gao Y. ; Chen S. ; Lu W. ; Gu W. ; Liu P. ; Sun P. 
Visible Light-Induced C3-Sulfonamidation of Imidazopyridines
with Sulfamides . Org. Biomol. Chem. 
2017 , 15 , 8102 –8109 . 10.1039/c7ob02029e .28905975  d Sun K. ; Li Y. ; Zhang Q. 
Copper-Catalyzed Arenes Amination with Saccharins . Sci. China: Chem. 
2015 , 58 , 1354 –1358 . 10.1007/s11426-015-5385-y .
a Allen L. J. ; Cabrera P. J. ; Lee M. ; Sanford M. S. 
N-Acyloxyphthalimides
as Nitrogen Radical Precursors in the Visible Light Photocatalyzed
Room Temperature C-H Amination of Arenes and Heteroarenes . J. Am. Chem. Soc. 
2014 , 136 , 5607 –5610 . 10.1021/ja501906x .24702705  b Rit R. K. ; Shankar M. ; Sahoo A. K. 
C-H imidation:
a distinct perspective of C-N bond formation . Org. Biomol. Chem. 
2017 , 15 , 1282 –1293 . 10.1039/c6ob02162j .28094407 
a Sun K. ; Li Y. ; Xiong T. ; Zhang J. ; Zhang Q. 
Palladium-Catalyzed C–H Aminations
of Anilides withN-Fluorobenzenesulfonimide . J. Am. Chem. Soc. 
2011 , 133 , 1694 –1697 . 10.1021/ja1101695 .21250687  b Kawakami T. ; Murakami K. ; Itami K. 
Catalytic C-H Imidation
of Aromatic Cores of Functional Molecules: Ligand-Accelerated Cu Catalysis
and Application to Materials-and Biology-Oriented Aromatics . J. Am. Chem. Soc. 
2015 , 137 , 2460 –2463 . 10.1021/ja5130012 .25669319  c Boursalian G. B. ; Ngai M.-Y. ; Hojczyk K. N. ; Ritter T. 
Pd-Catalyzed Aryl C-H Imidation with
Arene as the Limiting Reagent . J. Am. Chem.
Soc. 
2013 , 135 , 13278 –13281 . 10.1021/ja4064926 .23998528  d Ito E. ; Fukushima T. ; Kawakami T. ; Murakami K. ; Itami K. 
Catalytic Dehydrogenative C–H Imidation of Arenes Enabled
by Photo-generated Hole Donation to Sulfonimide . Chem 
2017 , 2 , 383 –392 . 10.1016/j.chempr.2017.02.006 .
Wang S. ; Ni Z. ; Huang X. ; Wang J. ; Pan Y. 
Copper-Catalyzed Direct
Amidation of Heterocycles with N-Fluorobenzenesulfonimide . Org. Lett. 
2014 , 16 , 5648 –5651 . 10.1021/ol502724u .25310043 
a Xie J. ; Wang Y.-W. ; Qi L.-W. ; Zhang B. 
Access to Aminated Saturated Oxygen Heterocycles via Copper-Catalyzed
Aminooxygenation of Alkenes . Org. Lett. 
2017 , 19 , 1148 –1151 . 10.1021/acs.orglett.7b00182 .28205441  b Li D. ; Mao T. ; Huang J. ; Zhu Q. 
Copper-Catalyzed
Regioselective 1,2-Thioamidation of Alkenes . Chem. Commun. 
2017 , 53 , 3450 –3453 . 10.1039/c7cc00083a .
a Ni Z. ; Zhang Q. ; Xiong T. ; Zheng Y. ; Li Y. ; Zhang H. ; Zhang J. ; Liu Q. 
Highly Regioselective Copper-Catalyzed Benzylic C-H Amination by
N-Fluorobenzenesulfonimide . Angew. Chem. 
2012 , 124 , 1270 –1273 . 10.1002/ange.201107427 . b Xiong T. ; Li Y. ; Lv Y. ; Zhang Q. 
Remote Amide-Directed
Palladium-Catalyzed Benzylic C-H Amination with N-Fluorobenzenesulfonimide . Chem. Commun. 
2010 , 46 , 6831 –6833 . 10.1039/c0cc02175j .
Li Y. ; Zhang Q. 
N-Fluorobenzenesulfonimide:
An Efficient Nitrogen Source for C-N
Bond Formation . Synthesis 
2015 , 47 , 159 –174 . 10.1055/s-0034-1379396 . b Reddy C. R. ; Prajapti S. K. ; Ranjan R. 
Cu(I)-Catalyzed Aminative
Aza-Annulation of Enynyl Azide using N-Fluorobenzenesulfonimide: Synthesis
of 5-Aminonicotinates . Org. Lett. 
2018 , 20 , 3128 –3131 . 10.1021/acs.orglett.8b01228 .29708757 
a Yoshimura A. ; Zhdankin V. V. 
Advances in Synthetic
Applications of Hypervalent Iodine Compounds . Chem. Rev. 
2016 , 116 , 3328 –3435 . 10.1021/acs.chemrev.5b00547 .26861673  b Merritt E. A. ; Olofsson B. 
Diaryliodonium Salts: A Journey from
Obscurity to Fame . Angew. Chem., Int. Ed. 
2009 , 48 , 9052 –9070 . 10.1002/anie.200904689 . c Liu D. ; Lei A. 
Iodine-Catalyzed Oxidative Coupling Reactions Utilizing
C-H and X-H as Nucleophiles . Chem.—Asian
J. 
2015 , 10 , 806 –823 . 10.1002/asia.201403248 .25683644 
a Kalbandhe A.
H. ; Kavale A. C. ; Karade N. N. 
Ring-Opening
Reaction of Imidazo[1,2-a]pyridines Using (Diacetoxyiodo)benzene and
NaN3: The Synthesis of α-Iminonitriles . Eur. J. Org. Chem. 
2017 , 1318 –1322 . 10.1002/ejoc.201601480 . b Manna S. ; Matcha K. ; Antonchick A. P. 
Metal-Free
Annulation of Arenes with 2-Aminopyridine Derivatives: The Methyl
Group as a Traceless Non-Chelating Directing Group . Angew. Chem., Int. Ed. 
2014 , 53 , 8163 –8166 . 10.1002/anie.201403712 . c Maiti S. ; Bose A. ; Mal P. 
Oxidative N-Arylation for Carbazole Synthesis by C-C Bond Activation . J. Org. Chem. 
2018 , 83 , 8127 –8138 . 10.1021/acs.joc.8b00921 .29847942 
a Manna S. ; Serebrennikova P. O. ; Utepova I. A. ; Antonchick A. P. ; Chupakhin O. N. 
Hypervalent
Iodine(III) in Direct Oxidative Amination of Arenes with Heteroaromatic
Amines . Org. Lett. 
2015 , 17 , 4588 –4591 . 10.1021/acs.orglett.5b02320 .26332538  b Kantak A. A. ; Potavathri S. ; Barham R. A. ; Romano K. M. ; DeBoef B. 
Metal-Free Intermolecular Oxidative C-N Bond Formation
via Tandem C-H and N-H Bond Functionalization . J. Am. Chem. Soc. 
2011 , 133 , 19960 –19965 . 10.1021/ja2087085 .22010982 
Wang Y. ; Wang Y. ; Guo Z. ; Zhang Q. ; Li D. 
Metal-Free
Oxidative C-H Amination of 8-Acylaminoquinolines and Anilides with
N-Fluorobenzenesulfonimide . Asian J. Org. Chem. 
2016 , 5 , 1438 –1441 . 10.1002/ajoc.201600389 .
Further information can be found in
the CIF
file. This crystal was deposited in the Cambridge Crystallographic
Data Centre and assigned as CCDC 1846489.


a Xiong T. ; Zhang Q. 
New Amination Strategies
Based on Nitrogen-Centered Radical Chemistry . Chem. Soc. Rev. 
2016 , 45 , 3069 –3087 . 10.1039/c5cs00852b .27116936  b Xiang D. ; Xia L. ; Zhang Y. ; Zhang Q. ; Li D. 
Remote Oxidative C–H Amidation of Anilides with Dibenzenesulfonimides
under Metal-Free Conditions . Synlett 
2018 , 29 , 1400 –1404 . 10.1055/s-0036-1591970 .

